PT - JOURNAL ARTICLE AU - Ramaloko, Winnie Thabisa AU - Sekyere, John Osei TI - Phylogenomics, Epigenomics, Virulome, and Mobilome of Gram-negative Bacteria Co-resistant to Carbapenems and Polymyxins: A One-Health Systematic Review and Meta-analyses AID - 10.1101/2021.07.03.21259964 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.03.21259964 4099 - http://medrxiv.org/content/early/2021/07/07/2021.07.03.21259964.short 4100 - http://medrxiv.org/content/early/2021/07/07/2021.07.03.21259964.full AB - Gram-negative bacteria (GNB) continue to develop resistance against important antibiotics including last-resort ones such as carbapenems and polymyxins. An analysis of GNB with co-resistance to carbapenems and polymyxins from a One Health perspective is presented.Data of species name, country, source of isolation, resistance genes (ARGs), plasmid type, clones, and mobile genetic elements (MGEs) were deduced from 129 articles from January 2016 to March 2021. Available genomes and plasmids were obtained from PATRIC and NCBI. Resistomes and methylomes were analysed using BAcWGSTdb and REBASE whilst Kaptive was used to predict capsule typing. Plasmids and other MEGs were identified using MGE Finder and ResFinder. Phylogenetic analyses were done using RAxML and annotated with MEGA 7.A total of 877 isolates, 32 genomes and 44 plasmid sequences were analysed. Most of these isolates were reported in Asian countries and were isolated from clinical, animal, and environmental sources. Colistin resistance was mostly mediated by mgrB inactivation, while OXA-48/181 was the most reported carbapenemase. IncX and IncI were the most common plasmids hosting carbapenemases and mcr genes. The isolates were co-resistant to other antibiotics, with floR (chloramphenicol) and fosA3 (fosfomycin) being common; E. coli ST156 and K. pneumoniae ST258 strains were common globally. Virulence genes and capsular KL-types were also detected. Type I, II, III and IV restriction modification systems were detected, comprising various MTases and restriction enzymes. The escalation of highly resistant isolates drains the economy due to untreatable bacterial infections, which leads to increasing global mortality rates and healthcare costs.Author summary Carbapenem and polymyxin co-resistance in Gram-negative bacteria (GNB) is a growing public health concern globally. China presented a high number of highly resistant bacteria from humans, animals, and environmental samples. Escherichia coli isolates were the most dominant in China, while Klebsiella pneumoniae isolates dominated Greece, the second country with high numbers of carbapenem and colistin co-resistant strains. Mobile genetic elements including plasmids are responsible for disseminating such resistance genes. Worryingly, GNB with Carbapenem and polymyxin co-resistance also harbours genes that make them resistant to other antibiotics, making them multi-drug resistant.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work required no ethical approval as no human or animal subjects, tissues, or data were involved.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data for this work are included in supplemental files